ARTICLE | Clinical News

Xyrem sodium oxybate regulatory update

October 11, 2010 7:00 AM UTC

Jazz said FDA noted that the agency received an ANDA for a generic sodium oxybate oral solution. Jazz said it has not received a Paragraph IV certification and intends to vigorously enforce its IP rig...